Bristol-Myers stops kidney cancer drug test after early success

(Reuters) - Bristol-Myers Squibb Co said on Thursday the success of its combination therapy to improve overall survival in kidney cancer patients helped it end the trial well ahead of schedule, despite earlier reporting mixed results on other main goals.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news